Boothbay Fund Management, LLC Phathom Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$17.83 - $33.15 $266,041 - $494,631	-14,921 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$30.69 - $36.83 $951 - $1,141	31 Added 0.21%	14,921 $479,000
Q2 2021 Aug 16, 2021	BUY	$32.66 - $39.87 $75,052 - $91,621	2,298 Added 18.25%	14,890 $504,000
Q1 2021 May 17, 2021	SELL	$33.86 - $48.68 $8,668 - $12,462	-256 Reduced 1.99%	12,592 $473,000
Q4 2020 Feb 12, 2021	BUY	$33.22 - $50.26 $426,810 - $645,740	12,848 New	12,848 $427,000

123

54.7M

34K

58.7K

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $402M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.